Atlas Trials

RWE on Patients With mPDAC Long-term Survival After Treatment With Liposomal Irinotecan

Clinical trial NCT06155136 · UNKNOWN

Trial details

NCT number
NCT06155136
Sponsor
Servier Affaires Médicales
Status
UNKNOWN
Study type
OBSERVATIONAL
Pancreatic Cancer Metastatic
Start date
2023-10-06
Primary completion
2024-03-30
Enrollment
163

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.